DLL3 and neoplasm: Regarding tumour localisation, pulmonary AC (19/39, 48.7%) and TC (37/96, 38.5%) showed a much higher rate of DLL3 positivity compared to GEP-NET (43/845, 5.1%; p < 0.001).